Molecular Templates, Inc. Reports First Quarter 2019 Financial Results

NEXT STORY
Interpace Diagnostics Reports First Quarter 2019 Financial Results and Provides Business Update
PREV STORY
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Press Release Oncology Venture is issuing 1,574,803 shares under its existing convertible loan note agreement with Negma Group LTD and Park Partners GP

author_avatar
NASDAQ Market News

Cellular Biomedicine Group Announces Results of 2018 Annual Meeting of Stockholders

author_avatar
NASDAQ Market News

Immunocore Reports Third Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News